E-LIB Suche - Ergebnisse für: Kasenda, B

1

67P Molecular testing and treatment of patients with advanc..:

Vannier, C. ; Martens, U.M. ; Bleckmann, A....
ESMO Open. 8 (2023) 1 - p. 100925 , 2023

Link: https://doi.org/10.1016/..

2

122P Molecular testing, treatment, and response of patients..:

Lange, S. ; Bleckmann, A. ; Kasenda, B....
ESMO Open. 8 (2023) 1 - p. 101932 , 2023

Link: https://doi.org/10.1016/..

3

50MO Adoptive cell therapy with tumor-infiltrating lymphocy..:

König, D. ; Chirindel, A. ; Sandholzer, M....
Immuno-Oncology and Technology. 20 (2023) - p. 100523 , 2023

Link: https://doi.org/10.1016/..

4

Targeting immunoliposomes to EGFR-positive glioblastoma:

Kasenda, B. ; König, D. ; Manni, M....
ESMO Open. 7 (2022) 1 - p. 100365 , 2022

Link: https://doi.org/10.1016/..

5

BICENTRIC PILOT STUDY ON AGE‐ADAPTED HIGH‐DOSE CHEMOTHERAPY..:

Schorb, E. ; Kasenda, B. ; Ihorst, G....
Hematological Oncology. 37 (2019) S2 - p. 271-271 , 2019

Link: https://doi.org/10.1002/..

6

OFF‐LABEL USE IN LYMPHOMA PATIENTS IN SWITZERLAND:

Herbrand, A.K. ; Schmitt, A.M. ; Joerger, M...
Hematological Oncology. 37 (2019) S2 - p. 537-538 , 2019

Link: https://doi.org/10.1002/..

7

High-dose thiotepa-based chemotherapy with autologous stem ..:

Schorb, E ; Fox, C P ; Fritsch, K...
Bone Marrow Transplantation. 52 (2017) 8 - p. 1113-1119 , 2017

Link: https://doi.org/10.1038/..

8

High-dose chemotherapy with autologous haematopoietic stem ..:

Kasenda, B ; Ihorst, G ; Schroers, R...
Leukemia. 31 (2017) 12 - p. 2623-2629 , 2017

Link: https://doi.org/10.1038/..

9

Serum lactate dehydrogenase as an early marker for outcome ..:

Diem, S ; Kasenda, B ; Spain, L...
British Journal of Cancer. 114 (2016) 3 - p. 256-261 , 2016

Link: https://doi.org/10.1038/..

10

High-dose methotrexate-based immuno-chemotherapy for elderl..:

Fritsch, K ; Kasenda, B ; Schorb, E...
Leukemia. 31 (2016) 4 - p. 846-852 , 2016

Link: https://doi.org/10.1038/..

11

Reporting quality of clinical trial protocols: a repeated c..:

Gryaznov, D ; von Niederhäusern, B ; Speich, B...
doi:10.1136/bmjopen-2021-053417. , 2023

Link: https://doi.org/10.1136/..

12

CONSOLIDATIVE HCT-ASCT IS SUPERIOR TO NON-MYELOABLATIVE CHE..:

Illerhaus, G ; Ferreri, A ; Binder, M...
https://portal.findresearcher.sdu.dk/da/publications/aa20b797-7472-487c-bf79-eaf3a1ba8229. , 2023

Link: https://portal.findresea..

13

Reporting quality of clinical trial protocols: a repeated c..:

Gryaznov, D ; von Niederhäusern, B ; Speich, B...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2021-053417. , 2022

Link: https://serval.unil.ch/n..

14

Nonregistration, discontinuation, and nonpublication of ran..:

Speich, B ; Gryaznov, D ; Busse, JW...
doi:10.1371/journal.pmed.1003980. , 2022

Link: https://doi.org/10.1371/..

15

Reporting quality of trial protocols improved for non-regul..:

Lohner, S ; Gryaznov, D ; von Niederhäusern, B...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jclinepi.2021.05.011. , 2021

Link: https://serval.unil.ch/n..